Early uncertainty about the safety of noninterferon antivirals in patients with liver cancer may have contributed to the slow acceptance of direct-acting antiviral agents in this population.
Omega-3 fatty acids downregulate expression of betacellulin in patients with NASH, providing a potential new avenue for prevention and treatment, a study has found.
For patients who experienced rapid and significant weight reduction while taking an SGLT-2 inhibitor or a GLP-1 agonist, ALT values normalized, suggesting a beneficial effect on liver health.
A scientist whose work was key to identifying, studying, and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist.
National survey data revealed a significant association between metabolic dysfunction-associated liver disease in patients aged 12-18 years and food insufficiency.